Abstract
Highly soluble and stable proteins are desirable for many different applications, from basic science to reaching a cancer patient in the form of a biological drug. For X-ray crystallography—where production of a protein crystal might take weeks and even months—a stable protein sample of high purity and concentration can greatly increase the chances of producing a well-diffracting crystal. For a patient receiving a specific protein drug, its safety, efficacy, and even cost are factors affected by its solubility and stability. Increased protein expression and protein stability can be achieved by randomly altering the coding sequence. As the number of mutants generated might be overwhelming, a powerful protein expression and stability screen is required. In this chapter, we describe a colony filtration technology, which allows us to screen random mutagenesis libraries for increased thermal stability—the Hot CoFi blot. We share how to create the random mutagenesis library, how to perform the Hot CoFi blot, and how to identify more thermally stable clones. We use the Tobacco Etch Virus protease as a target to exemplify the procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arndt MA, Krauss J, Schwarzenbacher R, Vu BK, Greene S, Rybak SM (2003) Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin’s lymphoma. Int J Cancer 107(5):822–829. https://doi.org/10.1002/ijc.11451
Chirino AJ, Mire-Sluis A (2004) Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 22(11):1383–1391. https://doi.org/10.1038/nbt1030
Huus K, Havelund S, Olsen HB, van de Weert M, Frokjaer S (2005) Thermal dissociation and unfolding of insulin. Biochemistry 44(33):11171–11177. https://doi.org/10.1021/bi0507940
Mulinacci F, Capelle MA, Gurny R, Drake AF, Arvinte T (2011) Stability of human growth hormone: influence of methionine oxidation on thermal folding. J Pharm Sci 100(2):451–463
Radek JT, Castellino FJ (1988) A differential scanning calorimetric investigation of the domains of recombinant tissue plasminogen activator. Arch Biochem Biophys 267(2):776–786
Schellekens H (2002) Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev Drug Discov 1(6):457–462. https://doi.org/10.1038/nrd818
Willuda J, Honegger A, Waibel R, Schubiger PA, Stahel R, Zangemeister-Wittke U, Pluckthun A (1999) High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 59(22):5758–5767
Wakankar AA, Feeney MB, Rivera J, Chen Y, Kim M, Sharma VK, Wang YJ (2010) Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. Bioconjug Chem 21(9):1588–1595. https://doi.org/10.1021/bc900434c
Roberts CJ (2014) Protein aggregation and its impact on product quality. Curr Opin Biotechnol 30:211–217. https://doi.org/10.1016/j.copbio.2014.08.001
Erickson B, Nelson WP (2012) Perspective on opportunities in industrial biotechnology in renewable chemicals. Biotechnol J 7(2):176–185. https://doi.org/10.1002/biot.201100069
Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, Huang W, Johnson D, Tsao J, Reboul J, Vaglio P, Hill DE, Vidal M, Delucas LJ, Luo M (2004) High-throughput expression of C. elegans proteins. Genome Res 14(10B):2102–2110. https://doi.org/10.1101/gr.2520504
Lesley SA (2001) High-throughput proteomics: protein expression and purification in the postgenomic world. Protein Expr Purif 22(2):159–164. https://doi.org/10.1006/prep.2001.1465
Sorensen HP, Mortensen KK (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Factories 4(1):1. https://doi.org/10.1186/1475-2859-4-1
Sorensen HP, Mortensen KK (2005) Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115(2):113–128. https://doi.org/10.1016/j.jbiotec.2004.08.004
Chen Y, Qiu S, Luan CH, Luo M (2008) A high throughput platform for eukaryotic genes. Methods Mol Biol 426:209–220. https://doi.org/10.1007/978-1-60327-058-8_13
Knaust RK, Nordlund P (2001) Screening for soluble expression of recombinant proteins in a 96-well format. Anal Biochem 297(1):79–85. https://doi.org/10.1006/abio.2001.5331
Lueking A, Horn M, Eickhoff H, Bussow K, Lehrach H, Walter G (1999) Protein microarrays for gene expression and antibody screening. Anal Biochem 270(1):103–111. https://doi.org/10.1006/abio.1999.4063
Makrides SC (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60(3):512–538
Christendat D, Yee A, Dharamsi A, Kluger Y, Savchenko A, Cort JR, Booth V, Mackereth CD, Saridakis V, Ekiel I, Kozlov G, Maxwell KL, Wu N, McIntosh LP, Gehring K, Kennedy MA, Davidson AR, Pai EF, Gerstein M, Edwards AM, Arrowsmith CH (2000) Structural proteomics of an archaeon. Nat Struct Biol 7(10):903–909. https://doi.org/10.1038/82823
Edwards AM, Arrowsmith CH, Christendat D, Dharamsi A, Friesen JD, Greenblatt JF, Vedadi M (2000) Protein production: feeding the crystallographers and NMR spectroscopists. Nat Struct Biol 7(Suppl):970–972. https://doi.org/10.1038/80751
Roodveldt C, Aharoni A, Tawfik DS (2005) Directed evolution of proteins for heterologous expression and stability. Curr Opin Struct Biol 15(1):50–56. https://doi.org/10.1016/j.sbi.2005.01.001
Welch M, Govindarajan S, Ness JE, Villalobos A, Gurney A, Minshull J, Gustafsson C (2009) Design parameters to control synthetic gene expression in Escherichia coli. PLoS One 4(9):e7002. https://doi.org/10.1371/journal.pone.0007002
Bjork A, Dalhus B, Mantzilas D, Sirevag R, Eijsink VG (2004) Large improvement in the thermal stability of a tetrameric malate dehydrogenase by single point mutations at the dimer-dimer interface. J Mol Biol 341(5):1215–1226. https://doi.org/10.1016/j.jmb.2004.06.079
Eijsink VG, Bjork A, Gaseidnes S, Sirevag R, Synstad B, van den Burg B, Vriend G (2004) Rational engineering of enzyme stability. J Biotechnol 113(1–3):105–120. https://doi.org/10.1016/j.jbiotec.2004.03.026
Fitzgerald J, Lugovskoy A (2011) Rational engineering of antibody therapeutics targeting multiple oncogene pathways. MAbs 3(3):299–309
Courtois F, Schneider CP, Agrawal NJ, Trout BL (2015) Rational design of biobetters with enhanced stability. J Pharm Sci 104(8):2433–2440. https://doi.org/10.1002/jps.24520
Ahmad S, Kamal MZ, Sankaranarayanan R, Rao NM (2008) Thermostable Bacillus subtilis lipases: in vitro evolution and structural insight. J Mol Biol 381(2):324–340. https://doi.org/10.1016/j.jmb.2008.05.063
Dumon C, Varvak A, Wall MA, Flint JE, Lewis RJ, Lakey JH, Morland C, Luginbuhl P, Healey S, Todaro T, DeSantis G, Sun M, Parra-Gessert L, Tan X, Weiner DP, Gilbert HJ (2008) Engineering hyperthermostability into a GH11 xylanase is mediated by subtle changes to protein structure. J Biol Chem 283(33):22557–22564. https://doi.org/10.1074/jbc.M800936200
Giver L, Gershenson A, Freskgard PO, Arnold FH (1998) Directed evolution of a thermostable esterase. Proc Natl Acad Sci U S A 95(22):12809–12813
Hao J, Berry A (2004) A thermostable variant of fructose bisphosphate aldolase constructed by directed evolution also shows increased stability in organic solvents. Protein Eng Des Sel 17(9):689–697. https://doi.org/10.1093/protein/gzh081
Richardson TH, Tan X, Frey G, Callen W, Cabell M, Lam D, Macomber J, Short JM, Robertson DE, Miller C (2002) A novel, high performance enzyme for starch liquefaction. Discovery and optimization of a low pH, thermostable alpha-amylase. J Biol Chem 277(29):26501–26507. https://doi.org/10.1074/jbc.M203183200
Wang Q, Xia T (2008) Enhancement of the activity and alkaline pH stability of Thermobifida fusca xylanase A by directed evolution. Biotechnol Lett 30(5):937–944. https://doi.org/10.1007/s10529-007-9508-1
Worn A, Auf der Maur A, Escher D, Honegger A, Barberis A, Pluckthun A (2000) Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. J Biol Chem 275(4):2795–2803
Zumarraga M, Bulter T, Shleev S, Polaina J, Martinez-Arias A, Plou FJ, Ballesteros A, Alcalde M (2007) In vitro evolution of a fungal laccase in high concentrations of organic cosolvents. Chem Biol 14(9):1052–1064. https://doi.org/10.1016/j.chembiol.2007.08.010
Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454(7203):486–491. https://doi.org/10.1038/nature07101
Warne T, Serrano-Vega MJ, Tate CG, Schertler GF (2009) Development and crystallization of a minimal thermostabilised G protein-coupled receptor. Protein Expr Purif 65(2):204–213
Andrews SR, Taylor EJ, Pell G, Vincent F, Ducros VM, Davies GJ, Lakey JH, Gilbert HJ (2004) The use of forced protein evolution to investigate and improve stability of family 10 xylanases. The production of Ca2+−independent stable xylanases. J Biol Chem 279(52):54369–54379. https://doi.org/10.1074/jbc.M409044200
van den Berg S, Lofdahl PA, Hard T, Berglund H (2006) Improved solubility of TEV protease by directed evolution. J Biotechnol 121(3):291–298. https://doi.org/10.1016/j.jbiotec.2005.08.006
Burgess-Brown NA, Sharma S, Sobott F, Loenarz C, Oppermann U, Gileadi O (2008) Codon optimization can improve expression of human genes in Escherichia coli: a multi-gene study. Protein Expr Purif 59(1):94–102. https://doi.org/10.1016/j.pep.2008.01.008
Reetz MT, Wu S (2009) Laboratory evolution of robust and enantioselective Baeyer-Villiger monooxygenases for asymmetric catalysis. J Am Chem Soc 131(42):15424–15432. https://doi.org/10.1021/ja906212k
Gileadi O, Burgess-Brown NA, Colebrook SM, Berridge G, Savitsky P, Smee CE, Loppnau P, Johansson C, Salah E, Pantic NH (2008) High throughput production of recombinant human proteins for crystallography. Methods Mol Biol 426:221–246. https://doi.org/10.1007/978-1-60327-058-8_14
Saez NJ, Vincentelli R (2014) High-throughput expression screening and purification of recombinant proteins in E. coli. Methods Mol Biol 1091:33–53. https://doi.org/10.1007/978-1-62703-691-7_3
Savitsky P, Bray J, Cooper CD, Marsden BD, Mahajan P, Burgess-Brown NA, Gileadi O (2010) High-throughput production of human proteins for crystallization: the SGC experience. J Struct Biol 172(1):3–13. https://doi.org/10.1016/j.jsb.2010.06.008
Structural Genomics C, China Structural Genomics C, Northeast Structural Genomics C, Graslund S, Nordlund P, Weigelt J, Hallberg BM, Bray J, Gileadi O, Knapp S, Oppermann U, Arrowsmith C, Hui R, Ming J, dhe-Paganon S, Park HW, Savchenko A, Yee A, Edwards A, Vincentelli R, Cambillau C, Kim R, Kim SH, Rao Z, Shi Y, Terwilliger TC, Kim CY, Hung LW, Waldo GS, Peleg Y, Albeck S, Unger T, Dym O, Prilusky J, Sussman JL, Stevens RC, Lesley SA, Wilson IA, Joachimiak A, Collart F, Dementieva I, Donnelly MI, Eschenfeldt WH, Kim Y, Stols L, Wu R, Zhou M, Burley SK, Emtage JS, Sauder JM, Thompson D, Bain K, Luz J, Gheyi T, Zhang F, Atwell S, Almo SC, Bonanno JB, Fiser A, Swaminathan S, Studier FW, Chance MR, Sali A, Acton TB, Xiao R, Zhao L, Ma LC, Hunt JF, Tong L, Cunningham K, Inouye M, Anderson S, Janjua H, Shastry R, Ho CK, Wang D, Wang H, Jiang M, Montelione GT, Stuart DI, Owens RJ, Daenke S, Schutz A, Heinemann U, Yokoyama S, Bussow K, Gunsalus KC (2008) Protein production and purification. Nat Methods 5(2):135–146. https://doi.org/10.1038/nmeth.f.202
Vincentelli R, Cimino A, Geerlof A, Kubo A, Satou Y, Cambillau C (2011) High-throughput protein expression screening and purification in Escherichia coli. Methods 55(1):65–72. https://doi.org/10.1016/j.ymeth.2011.08.010
Lutz S (2010) Beyond directed evolution – semi-rational protein engineering and design. Curr Opin Biotechnol 21(6):734–743. https://doi.org/10.1016/j.copbio.2010.08.011
Yang JS, Seo SW, Jang S, Jung GY, Kim S (2012) Rational engineering of enzyme allosteric regulation through sequence evolution analysis. PLoS Comput Biol 8(7):e1002612. https://doi.org/10.1371/journal.pcbi.1002612
Steiner K, Schwab H (2012) Recent advances in rational approaches for enzyme engineering. Comput Struct Biotechnol J 2:e201209010. https://doi.org/10.5936/csbj.201209010
Jemli S, Ayadi-Zouari D, Hlima HB, Bejar S (2016) Biocatalysts: application and engineering for industrial purposes. Crit Rev Biotechnol 36(2):246–258. https://doi.org/10.3109/07388551.2014.950550
Lehmann M, Wyss M (2001) Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution. Curr Opin Biotechnol 12(4):371–375
Ewert S, Honegger A, Pluckthun A (2004) Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. Methods 34(2):184–199. https://doi.org/10.1016/j.ymeth.2004.04.007
Bloom JD, Labthavikul ST, Otey CR, Arnold FH (2006) Protein stability promotes evolvability. Proc Natl Acad Sci U S A 103(15):5869–5874. https://doi.org/10.1073/pnas.0510098103
Hart DJ, Waldo GS (2013) Library methods for structural biology of challenging proteins and their complexes. Curr Opin Struct Biol 23(3):403–408. https://doi.org/10.1016/j.sbi.2013.03.004
Yumerefendi H, Desravines DC, Hart DJ (2011) Library-based methods for identification of soluble expression constructs. Methods 55(1):38–43. https://doi.org/10.1016/j.ymeth.2011.06.007
Yumerefendi H, Tarendeau F, Mas PJ, Hart DJ (2010) ESPRIT: an automated, library-based method for mapping and soluble expression of protein domains from challenging targets. J Struct Biol 172(1):66–74. https://doi.org/10.1016/j.jsb.2010.02.021
Coco WM, Levinson WE, Crist MJ, Hektor HJ, Darzins A, Pienkos PT, Squires CH, Monticello DJ (2001) DNA shuffling method for generating highly recombined genes and evolved enzymes. Nat Biotechnol 19(4):354–359. https://doi.org/10.1038/86744
Packer MS, Liu DR (2015) Methods for the directed evolution of proteins. Nat Rev Genet 16(7):379–394. https://doi.org/10.1038/nrg3927
Arnold FH (2009) How proteins adapt: lessons from directed evolution. Cold Spring Harb Symp Quant Biol 74:41–46. https://doi.org/10.1101/sqb.2009.74.046
Farinas ET, Bulter T, Arnold FH (2001) Directed enzyme evolution. Curr Opin Biotechnol 12(6):545–551
Tracewell CA, Arnold FH (2009) Directed enzyme evolution: climbing fitness peaks one amino acid at a time. Curr Opin Chem Biol 13(1):3–9. https://doi.org/10.1016/j.cbpa.2009.01.017
Romero PA, Arnold FH (2009) Exploring protein fitness landscapes by directed evolution. Nat Rev Mol Cell Biol 10(12):866–876. https://doi.org/10.1038/nrm2805
Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P (2006) Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem 357(2):289–298. https://doi.org/10.1016/j.ab.2006.07.027
Vedadi M, Arrowsmith CH, Allali-Hassani A, Senisterra G, Wasney GA (2010) Biophysical characterization of recombinant proteins: a key to higher structural genomics success. J Struct Biol 172(1):107–119. https://doi.org/10.1016/j.jsb.2010.05.005
Deller MC, Kong L, Rupp B (2016) Protein stability: a crystallographer’s perspective. Acta Crystallogr F Struct Biol Commun 72(Pt 2):72–95. https://doi.org/10.1107/S2053230X15024619
Hew K, Dahlroth SL, Veerappan S, Pan LX, Cornvik T, Nordlund P (2015) Structure of the Varicella Zoster virus thymidylate synthase establishes functional and structural similarities as the human enzyme and potentiates itself as a target of brivudine. PLoS One 10(12):e0143947. https://doi.org/10.1371/journal.pone.0143947
Hew K, Dahlroth SL, Venkatachalam R, Nasertorabi F, Lim BT, Cornvik T, Nordlund P (2013) The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Nucleic Acids Res 41(7):4295–4306. https://doi.org/10.1093/nar/gkt082
Larsson EA, Jansson A, Ng FM, Then SW, Panicker R, Liu B, Sangthongpitag K, Pendharkar V, Tai SJ, Hill J, Dan C, Ho SY, Cheong WW, Poulsen A, Blanchard S, Lin GR, Alam J, Keller TH, Nordlund P (2013) Fragment-based ligand design of novel potent inhibitors of tankyrases. J Med Chem 56(11):4497–4508. https://doi.org/10.1021/jm400211f
Almqvist H, Axelsson H, Jafari R, Dan C, Mateus A, Haraldsson M, Larsson A, Martinez Molina D, Artursson P, Lundback T, Nordlund P (2016) CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil. Nat Commun 7:11040. https://doi.org/10.1038/ncomms11040
Guettou F, Quistgaard EM, Raba M, Moberg P, Low C, Nordlund P (2014) Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2. Nat Struct Mol Biol 21(8):728–731. https://doi.org/10.1038/nsmb.2860
Ratanji KD, Derrick JP, Dearman RJ, Kimber I (2014) Immunogenicity of therapeutic proteins: influence of aggregation. J Immunotoxicol 11(2):99–109. https://doi.org/10.3109/1547691X.2013.821564
Cornvik T, Dahlroth SL, Magnusdottir A, Herman MD, Knaust R, Ekberg M, Nordlund P (2005) Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods 2(7):507–509. https://doi.org/10.1038/nmeth767
Dahlroth SL, Nordlund P, Cornvik T (2006) Colony filtration blotting for screening soluble expression in Escherichia coli. Nat Protoc 1(1):253–258. https://doi.org/10.1038/nprot.2006.39
Cornvik T, Dahlroth SL, Magnusdottir A, Flodin S, Engvall B, Lieu V, Ekberg M, Nordlund P (2006) An efficient and generic strategy for producing soluble human proteins and domains in E. coli by screening construct libraries. Proteins 65(2):266–273. https://doi.org/10.1002/prot.21090
Dahlroth SL, Lieu V, Haas J, Nordlund P (2009) Screening colonies of pooled ORFeomes (SCOOP): a rapid and efficient strategy for expression screening ORFeomes in Escherichia coli. Protein Expr Purif 68(2):121–127. https://doi.org/10.1016/j.pep.2009.07.010
Martinez Molina D, Cornvik T, Eshaghi S, Haeggstrom JZ, Nordlund P, Sabet MI (2008) Engineering membrane protein overproduction in Escherichia coli. Protein Sci 17(4):673–680. https://doi.org/10.1110/ps.073242508
Cabantous S, Pedelacq JD, Mark BL, Naranjo C, Terwilliger TC, Waldo GS (2005) Recent advances in GFP folding reporter and split-GFP solubility reporter technologies. Application to improving the folding and solubility of recalcitrant proteins from Mycobacterium tuberculosis. J Struct Funct Genom 6(2–3):113–119. https://doi.org/10.1007/s10969-005-5247-5
Waldo GS, Standish BM, Berendzen J, Terwilliger TC (1999) Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 17(7):691–695. https://doi.org/10.1038/10904
Maxwell KL, Mittermaier AK, Forman-Kay JD, Davidson AR (1999) A simple in vivo assay for increased protein solubility. Protein Sci 8(9):1908–1911. https://doi.org/10.1110/ps.8.9.1908
Fisher AC, Kim W, DeLisa MP (2006) Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci 15(3):449–458. https://doi.org/10.1110/ps.051902606
Lockard MA, Listwan P, Pedelacq JD, Cabantous S, Nguyen HB, Terwilliger TC, Waldo GS (2011) A high-throughput immobilized bead screen for stable proteins and multi-protein complexes. Protein Eng Des Sel 24(7):565–578. https://doi.org/10.1093/protein/gzr021
Peabody DS, Al-Bitar L (2001) Isolation of viral coat protein mutants with altered assembly and aggregation properties. Nucleic Acids Res 29(22):E113
Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ (2001) Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat Biotechnol 19(2):131–136. https://doi.org/10.1038/84389
Chautard H, Blas-Galindo E, Menguy T, Grand’Moursel L, Cava F, Berenguer J, Delcourt M (2007) An activity-independent selection system of thermostable protein variants. Nat Methods 4(11):919–921. https://doi.org/10.1038/nmeth1090
Foit L, Morgan GJ, Kern MJ, Steimer LR, von Hacht AA, Titchmarsh J, Warriner SL, Radford SE, Bardwell JC (2009) Optimizing protein stability in vivo. Mol Cell 36(5):861–871. https://doi.org/10.1016/j.molcel.2009.11.022
Martin A, Schmid FX, Sieber V (2003) Proside: a phage-based method for selecting thermostable proteins. Methods Mol Biol 230:57–70. https://doi.org/10.1385/1-59259-396-8:57
Sieber V, Pluckthun A, Schmid FX (1998) Selecting proteins with improved stability by a phage-based method. Nat Biotechnol 16(10):955–960. https://doi.org/10.1038/nbt1098-955
Asial I, Cheng YX, Engman H, Dollhopf M, Wu B, Nordlund P, Cornvik T (2013) Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell. Nat Commun 4:2901. https://doi.org/10.1038/ncomms3901
Competing Financial Interests
S.D. and P.N. are co-founders of Evitra AB that owns the commercial rights to this method. I.A. and P.N. are co-founders of DotBio Pte. Ltd., which has licensed this method.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Asial, I., Nordlund, P., Dahlroth, SL. (2019). Hot CoFi Blot: A High-Throughput Colony-Based Screen for Identifying More Thermally Stable Protein Variants. In: Vincentelli, R. (eds) High-Throughput Protein Production and Purification. Methods in Molecular Biology, vol 2025. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9624-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9624-7_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9623-0
Online ISBN: 978-1-4939-9624-7
eBook Packages: Springer Protocols